WallStreetZenWallStreetZen

NASDAQ: MLAB
Mesa Laboratories Inc Stock Forecast, Predictions & Price Target

Analyst price target for MLAB

Based on 2 analysts offering 12 month price targets for Mesa Laboratories Inc.
Min Forecast
$205.00+3.6%
Avg Forecast
$235.00+18.76%
Max Forecast
$265.00+33.93%

Should I buy or sell MLAB stock?

Based on 3 analysts offering ratings for Mesa Laboratories Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MLAB stock forecasts and price targets.

Forecast return on equity

Is MLAB forecast to generate an efficient return?
Company
14.23%
Industry
15.57%
Market
57.51%
MLAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MLAB forecast to generate an efficient return on assets?
Company
8.12%
Industry
6.72%
MLAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MLAB earnings per share forecast

What is MLAB's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$6.08
Avg 2 year Forecast
$7.54
Avg 3 year Forecast
$9.98

MLAB revenue forecast

What is MLAB's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$222.8M+0.02%
Avg 2 year Forecast
$239.0M+7.29%
Avg 3 year Forecast
$271.0M+21.65%
MLAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MLAB revenue growth forecast

How is MLAB forecast to perform vs Scientific & Technical Instruments companies and vs the US market?
Company
4.43%
Industry
18.28%
Market
11.03%
MLAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MLAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MLAB vs Scientific & Technical Instrument Stocks

TickerPricePrice TargetUp/downsideConsensus
MLAB$197.87$235.00+18.76%Buy
VPG$43.92$48.00+9.29%Strong Buy
FARO$29.01$39.50+36.16%Buy
MVIS$3.26$5.00+53.37%Hold
VLDR$1.49$1.54+3.22%Hold

Mesa Laboratories Stock Forecast FAQ

Is Mesa Laboratories Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MLAB) stock is to Buy MLAB stock.

Out of 3 analysts, 1 (33.33%) are recommending MLAB as a Strong Buy, 0 (0%) are recommending MLAB as a Buy, 2 (66.67%) are recommending MLAB as a Hold, 0 (0%) are recommending MLAB as a Sell, and 0 (0%) are recommending MLAB as a Strong Sell.

If you're new to stock investing, here's how to buy Mesa Laboratories stock.

What is MLAB's earnings growth forecast for 2023-2025?

(NASDAQ: MLAB) Mesa Laboratories's forecast annual earnings growth rate of N/A is not forecast to beat the US Scientific & Technical Instruments industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of 27.21%.

Mesa Laboratories's earnings in 2023 is -$3,976,000.On average, 2 Wall Street analysts forecast MLAB's earnings for 2023 to be $32,447,787, with the lowest MLAB earnings forecast at $28,071,605, and the highest MLAB earnings forecast at $36,770,600. On average, 2 Wall Street analysts forecast MLAB's earnings for 2024 to be $40,239,525, with the lowest MLAB earnings forecast at $39,439,004, and the highest MLAB earnings forecast at $41,040,046.

In 2025, MLAB is forecast to generate $53,261,334 in earnings, with the lowest earnings forecast at $53,261,334 and the highest earnings forecast at $53,261,334.

What is MLAB's revenue growth forecast for 2023-2025?

(NASDAQ: MLAB) Mesa Laboratories's forecast annual revenue growth rate of 4.43% is not forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 18.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.03%.

Mesa Laboratories's revenue in 2023 is $222,777,000.On average, 3 Wall Street analysts forecast MLAB's revenue for 2023 to be $1,189,147,336, with the lowest MLAB revenue forecast at $1,177,086,152, and the highest MLAB revenue forecast at $1,195,444,768. On average, 3 Wall Street analysts forecast MLAB's revenue for 2024 to be $1,275,566,251, with the lowest MLAB revenue forecast at $1,254,683,326, and the highest MLAB revenue forecast at $1,307,517,715.

In 2025, MLAB is forecast to generate $1,446,274,697 in revenue, with the lowest revenue forecast at $1,446,274,697 and the highest revenue forecast at $1,446,274,697.

What is MLAB's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: MLAB) forecast ROA is 8.12%, which is higher than the forecast US Scientific & Technical Instruments industry average of 6.72%.

What is MLAB's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MLAB price target, the average MLAB price target is $235.00, with the highest MLAB stock price forecast at $265.00 and the lowest MLAB stock price forecast at $205.00.

On average, Wall Street analysts predict that Mesa Laboratories's share price could reach $235.00 by Aug 11, 2023. The average Mesa Laboratories stock price prediction forecasts a potential upside of 18.76% from the current MLAB share price of $197.87.

What is MLAB's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: MLAB) Mesa Laboratories's current Earnings Per Share (EPS) is -$0.75. On average, analysts forecast that MLAB's EPS will be $6.08 for 2023, with the lowest EPS forecast at $5.26, and the highest EPS forecast at $6.89. On average, analysts forecast that MLAB's EPS will be $7.54 for 2024, with the lowest EPS forecast at $7.39, and the highest EPS forecast at $7.69. In 2025, MLAB's EPS is forecast to hit $9.98 (min: $9.98, max: $9.98).

What is MLAB's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: MLAB) forecast ROE is 14.23%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.